These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
585 related articles for article (PubMed ID: 30621694)
21. Exosomal Linc00969 induces trastuzumab resistance in breast cancer by increasing HER-2 protein expression and mRNA stability by binding to HUR. Liu C; Lu C; Yixi L; Hong J; Dong F; Ruan S; Hu T; Zhao X Breast Cancer Res; 2023 Oct; 25(1):124. PubMed ID: 37848981 [TBL] [Abstract][Full Text] [Related]
22. Correlation between long non-coding RNAs (lncRNAs) H19 expression and trastuzumab resistance in breast cancer. Sun Z; Zhang C; Wang T; Shi P; Tian X; Guo Y J Cancer Res Ther; 2019; 15(4):933-940. PubMed ID: 31436255 [TBL] [Abstract][Full Text] [Related]
23. MiR-129-5p Sensitizes the Response of Her-2 Positive Breast Cancer to Trastuzumab by Reducing Rps6. Lu X; Ma J; Chu J; Shao Q; Zhang Y; Lu G; Li J; Huang X; Li W; Li Y; Ling Y; Zhao T Cell Physiol Biochem; 2017; 44(6):2346-2356. PubMed ID: 29258115 [TBL] [Abstract][Full Text] [Related]
24. SP1-induced lncRNA TINCR overexpression contributes to colorectal cancer progression by sponging miR-7-5p. Yu S; Wang D; Shao Y; Zhang T; Xie H; Jiang X; Deng Q; Jiao Y; Yang J; Cai C; Sun L Aging (Albany NY); 2019 Mar; 11(5):1389-1403. PubMed ID: 30853664 [TBL] [Abstract][Full Text] [Related]
25. LncRNA DLEU1/microRNA-300/RAB22A axis regulates migration and invasion of breast cancer cells. Wang C; Xie XX; Li WJ; Jiang DQ Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10410-10421. PubMed ID: 31841195 [TBL] [Abstract][Full Text] [Related]
26. Long non-coding RNA CASC2 suppresses epithelial-mesenchymal transition of hepatocellular carcinoma cells through CASC2/miR-367/FBXW7 axis. Wang Y; Liu Z; Yao B; Li Q; Wang L; Wang C; Dou C; Xu M; Liu Q; Tu K Mol Cancer; 2017 Jul; 16(1):123. PubMed ID: 28716020 [TBL] [Abstract][Full Text] [Related]
27. Up-regulation of ceRNA TINCR by SP1 contributes to tumorigenesis in breast cancer. Liu Y; Du Y; Hu X; Zhao L; Xia W BMC Cancer; 2018 Apr; 18(1):367. PubMed ID: 29614984 [TBL] [Abstract][Full Text] [Related]
28. Overexpression of lncRNA TINCR is associated with high-grade, invasive, and recurring tumors, and facilitates proliferation in vitro and in vivo of urothelial carcinoma of the bladder. Han Y; Sun G Urol Oncol; 2020 Sep; 38(9):738.e1-738.e8. PubMed ID: 32622721 [TBL] [Abstract][Full Text] [Related]
29. Long non-coding RNAs AC026904.1 and UCA1: a "one-two punch" for TGF-β-induced SNAI2 activation and epithelial-mesenchymal transition in breast cancer. Li GY; Wang W; Sun JY; Xin B; Zhang X; Wang T; Zhang QF; Yao LB; Han H; Fan DM; Yang AG; Jia LT; Wang L Theranostics; 2018; 8(10):2846-2861. PubMed ID: 29774079 [TBL] [Abstract][Full Text] [Related]
30. lncRNA TINCR attenuates the proliferation and invasion, and enhances the apoptosis of cutaneous malignant melanoma cells by regulating the miR‑424‑5p/LATS1 axis. Han X; Jia Y; Chen X; Sun C; Sun J Oncol Rep; 2021 Nov; 46(5):. PubMed ID: 34542165 [TBL] [Abstract][Full Text] [Related]
31. SNHG7 accelerates cell migration and invasion through regulating miR-34a-Snail-EMT axis in gastric cancer. Zhang Y; Yuan Y; Zhang Y; Cheng L; Zhou X; Chen K Cell Cycle; 2020 Jan; 19(1):142-152. PubMed ID: 31814518 [TBL] [Abstract][Full Text] [Related]
32. Long non-coding RNA terminal differentiation-induced non-coding RNA regulates cisplatin resistance of choroidal melanoma by positively modulating extracellular signal-regulated kinase 2 via sponging microRNA-19b-3p. Li W; Nie A; Jin L; Cui Y; Xie N; Liang G Bioengineered; 2022 Feb; 13(2):3422-3433. PubMed ID: 35067169 [TBL] [Abstract][Full Text] [Related]
33. Long non-coding RNA PGM5-AS1 promotes epithelial-mesenchymal transition, invasion and metastasis of osteosarcoma cells by impairing miR-140-5p-mediated FBN1 inhibition. Liu W; Liu P; Gao H; Wang X; Yan M Mol Oncol; 2020 Oct; 14(10):2660-2677. PubMed ID: 32412676 [TBL] [Abstract][Full Text] [Related]
34. Spontaneous epithelial-mesenchymal transition and resistance to HER-2-targeted therapies in HER-2-positive luminal breast cancer. Lesniak D; Sabri S; Xu Y; Graham K; Bhatnagar P; Suresh M; Abdulkarim B PLoS One; 2013; 8(8):e71987. PubMed ID: 23991019 [TBL] [Abstract][Full Text] [Related]
35. BCAR4 facilitates trastuzumab resistance and EMT in breast cancer via sponging miR-665 and interacting with YAP1. Ye X; Liu Q; Qin X; Ma Y; Sheng Q; Wu X; Chen S; Huang L; Sun Y FASEB J; 2024 Apr; 38(7):e23589. PubMed ID: 38572594 [TBL] [Abstract][Full Text] [Related]
36. Long noncoding RNA AC073284.4 suppresses epithelial-mesenchymal transition by sponging miR-18b-5p in paclitaxel-resistant breast cancer cells. Wang YY; Yan L; Yang S; Xu HN; Chen TT; Dong ZY; Chen SL; Wang WR; Yang QL; Chen CJ J Cell Physiol; 2019 Dec; 234(12):23202-23215. PubMed ID: 31215650 [TBL] [Abstract][Full Text] [Related]
37. SP1-activated long noncoding RNA lncRNA GCMA functions as a competing endogenous RNA to promote tumor metastasis by sponging miR-124 and miR-34a in gastric cancer. Tian Y; Ma R; Sun Y; Liu H; Zhang H; Sun Y; Liu L; Li Y; Song L; Gao P Oncogene; 2020 Jun; 39(25):4854-4868. PubMed ID: 32439864 [TBL] [Abstract][Full Text] [Related]
38. MCRS1 overexpression, which is specifically inhibited by miR-129*, promotes the epithelial-mesenchymal transition and metastasis in non-small cell lung cancer. Liu MX; Zhou KC; Cao Y Mol Cancer; 2014 Nov; 13():245. PubMed ID: 25373388 [TBL] [Abstract][Full Text] [Related]
39. LncRNA SNHG6 knockdown inhibits cisplatin resistance and progression of gastric cancer through miR-1297/BCL-2 axis. Mei J; Liu G; Li R; Xiao P; Yang D; Bai H; Hao Y Biosci Rep; 2021 Dec; 41(12):. PubMed ID: 34821362 [TBL] [Abstract][Full Text] [Related]
40. Long noncoding RNA NORAD, a novel competing endogenous RNA, enhances the hypoxia-induced epithelial-mesenchymal transition to promote metastasis in pancreatic cancer. Li H; Wang X; Wen C; Huo Z; Wang W; Zhan Q; Cheng D; Chen H; Deng X; Peng C; Shen B Mol Cancer; 2017 Nov; 16(1):169. PubMed ID: 29121972 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]